 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $56.892,37 | (19/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.900,72 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $57.438,84 | (19/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.168,72 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $57.438,84 | (19/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.168,72 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $57.438,84 | (19/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $28.168,72 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $60.744,80 | (19/11/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.790,01 |
|
|
|
|
| |
